GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Wuxi AppTec Co Ltd (HKSE:02359) » Definitions » Selling and Marketing Expense

Wuxi AppTec Co (HKSE:02359) Selling and Marketing Expense : HK$256 Mil (TTM As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Wuxi AppTec Co Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Wuxi AppTec Co's Selling and Marketing Expense for the three months ended in Mar. 2025 was HK$208 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2025 was HK$256 Mil.


Wuxi AppTec Co Selling and Marketing Expense Historical Data

The historical data trend for Wuxi AppTec Co's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuxi AppTec Co Selling and Marketing Expense Chart

Wuxi AppTec Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Selling and Marketing Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 140.51 182.81 211.18 205.63 224.76

Wuxi AppTec Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 194.55 -72.43 478.70 -358.82 208.07

Wuxi AppTec Co Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$256 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wuxi AppTec Co Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Wuxi AppTec Co's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuxi AppTec Co Business Description

Traded in Other Exchanges
Address
288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, CHN, 200131
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by China, Europe, and other regions.
Executives
Computershare Hong Kong Trustees Limited 2301 Trustee
Fmr Llc 2201 Interest of corporation controlled by you
Jpmorgan Chase & Co.
Ubs Group Ag 2201 Interest of corporation controlled by you
Invesco Advisers, Inc. 2102 Investment manager
Blackrock, Inc. 2201 Interest of corporation controlled by you
Morgan Stanley 2201 Interest of corporation controlled by you
Citigroup Inc. 2201 Interest of corporation controlled by you
Schroders Plc 2102 Investment manager
The Capital Group Companies, Inc. 2201 Interest of corporation controlled by you
The Goldman Sachs Group, Inc.
Brown Brothers Harriman & Co. 2502 Approved lending agent
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Fil Limited 2201 Interest of corporation controlled by you

Wuxi AppTec Co Headlines

No Headlines